BRAF and melanoma: Taken together, we have identified a compound that is effective in inducing apoptosis in both BRAFV600E and BRAF WT melanoma and has the potential to be readily translated to the clinic especially in the case of BRAF WT melanoma where fewer approved treatment options exist.